Pharma Marketing Network

SEPTEMBER 22, 2021

Panelists: Tim Glennon , Vice President of Marketing, Evofem Biosciences. Licensed Clinical Psychologist, Clinical Director, Virtual Counselor/College Telehealth. Robert Schildt , Senior Director, Go-To-Market Innovation, Biohaven Pharmaceuticals. Marketing Agility – the Path to Digital Engagement & Innovation.

Big Data 52

Big Data Marketing Life Science Licensing 52

Pharma Marketing Network

SEPTEMBER 22, 2021

Panelists: Tim Glennon , Vice President of Marketing, Evofem Biosciences. Licensed Clinical Psychologist, Clinical Director, Virtual Counselor/College Telehealth. Robert Schildt , Senior Director, Go-To-Market Innovation, Biohaven Pharmaceuticals. Marketing Agility – the Path to Digital Engagement & Innovation.

Big Data 40

Big Data Marketing Life Science Licensing 40

pharmaphorum

OCTOBER 16, 2020

These might be licensed drugs that could hold potential for a patent extension, or drugs which failed efficacy trials for an intended indication. In the quest to repurpose a drug for a rare condition, there is a need to look at any and all available data. The post Rare diseases, repurposing and the role of AI appeared first on.

Clinical Trials 99

Clinical Trials Clinical Trials Trials Life Science 99

pharmaphorum

SEPTEMBER 18, 2020

German and Swiss pharma companies dominated the Swedish market at this time and it wasn’t until 1913 that the discussions were turned into a pharmaceutical company, Astra AB. Astra introduced two important product families onto the Swedish market in 1948: penicillin and anaesthetics, initially in the form of Xylocaine.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

Drug Discovery World

SEPTEMBER 6, 2022

Indeed, the growth of the cell and gene therapy market, coupled with the demand that the pandemic placed on manufacturing capacity, means the industry faces shortages of these crucial materials. The challenge for the market then, according to Boissel, is how much can a payor afford to pay upfront? . Workforce .

Gene Therapy 52

Gene Therapy Gene Manufacturing Medicine 52

XTalks

AUGUST 2, 2023

Join us as we present an in-depth analysis of each company’s revenue, net income, R&D investments, core therapeutic areas, market presence and strategic collaborations. is a global pharmaceutical company, working across both developed and emerging markets. 2022 Revenue: Pfizer reported an annual revenue of $100.33 Pfizer Inc.

Sales 98

Sales Manufacturing FDA Approval Life Science 98